All lobbying filings
NOVAVAX, INC
NOVAVAX, INC filed a Q1 report for NOVAVAX, INC on April 28, 2025.
Lobbying for NOVAVAX, INC
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 28, 2025
Expenses
$170,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Maryland
Government bodies contacted
3
Lobbying activity
1
Issues related to COVID-19 vaccines Reauthorization of Pandemic and All-Hazards Preparedness Act General discussions related to vaccine injury compensation programs and vaccine strain selection timelines.